title: Clarifications to the standard neutrophil response criteria for clinical trials in myelodysplastic syndromes are needed.
authors.forename: D P
authors.initials: DP
authors.lastname: Steensma
authors.forename: L
authors.initials: L
authors.lastname: Letendre
authors.forename: A
authors.initials: A
authors.lastname: Tefferi
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D007958:Leukocyte Count; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000188:drug therapy*; D009504:Neutrophils